Kevin Caliendo
Stock Analyst at UBS
(4.59)
# 252
Out of 5,152 analysts
207
Total ratings
73.79%
Success rate
12.82%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $10 → $5 | $3.40 | +47.06% | 4 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Buy | $48 → $57 | $44.05 | +29.40% | 2 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $12 | $6.95 | +72.66% | 7 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Neutral | $79 → $87 | $80.17 | +8.52% | 7 | Feb 25, 2026 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $210 | $203.98 | +2.95% | 17 | Feb 11, 2026 | |
| ALGN Align Technology | Maintains: Neutral | $175 → $185 | $175.60 | +5.35% | 20 | Feb 5, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $17 → $16 | $13.33 | +20.03% | 13 | Feb 3, 2026 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $25 | $27.93 | -10.49% | 5 | Feb 3, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $18.57 | +13.09% | 9 | Jan 14, 2026 | |
| CVS CVS Health | Maintains: Buy | $96 → $97 | $78.69 | +23.27% | 11 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $77 → $79 | $70.78 | +11.61% | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $380 → $415 | $359.28 | +15.51% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.29 | +74.67% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $920 → $980 | $931.35 | +5.22% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $216.02 | +1.84% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $288.77 | +48.91% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $275.92 | +15.98% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $147.71 | +15.09% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.61 | +60.43% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $281.27 | +38.66% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $180.75 | +38.31% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $43.27 | +82.57% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $286.48 | +100.71% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $239.63 | -24.88% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $5.12 | +1,306.25% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $31.75 | -65.35% | 4 | May 4, 2021 |
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $3.40
Upside: +47.06%
Medline
Feb 26, 2026
Maintains: Buy
Price Target: $48 → $57
Current: $44.05
Upside: +29.40%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.95
Upside: +72.66%
Henry Schein
Feb 25, 2026
Maintains: Neutral
Price Target: $79 → $87
Current: $80.17
Upside: +8.52%
Quest Diagnostics
Feb 11, 2026
Maintains: Neutral
Price Target: $190 → $210
Current: $203.98
Upside: +2.95%
Align Technology
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $175.60
Upside: +5.35%
DENTSPLY SIRONA
Feb 3, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $13.33
Upside: +20.03%
Envista Holdings
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $27.93
Upside: -10.49%
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $18.57
Upside: +13.09%
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $78.69
Upside: +23.27%
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $70.78
Upside: +11.61%
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $359.28
Upside: +15.51%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.29
Upside: +74.67%
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $931.35
Upside: +5.22%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $216.02
Upside: +1.84%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $288.77
Upside: +48.91%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $275.92
Upside: +15.98%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $147.71
Upside: +15.09%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.61
Upside: +60.43%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $281.27
Upside: +38.66%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $180.75
Upside: +38.31%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $43.27
Upside: +82.57%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $286.48
Upside: +100.71%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $239.63
Upside: -24.88%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $5.12
Upside: +1,306.25%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $31.75
Upside: -65.35%